CRESCO LABS TO TRANSFORM THE MEDICAL MARIJUANA INDUSTRY IN OHIOhttps://www.crescolabs.com/wp-content/uploads/2018/12/ohio-w.png 750 750 admin admin https://secure.gravatar.com/avatar/018ce1536159deab276cd049fdbfd382?s=96&d=mm&r=g
Granted Approval to Open the State’s First Medical Marijuana Dispensary
Wintersville, OH – December [11 ], 2018 – Cresco Labs (CSE:CL), one of the largest vertically integrated multistate cannabis operators in the United States, today announced that it has been granted the first approval to operate a marijuana dispensary in the state of Ohio. The new facility located in the village of Wintersville, named CY+ (pronounced “see why plus”), will offer a wide selection of pharmaceutical- grade cannabis for physician-certified patients across Ohio.
“Receiving the first approval to operate is a major milestone in the transformation of the cannabis program in Ohio,” said Charles Bachtell, CEO of Cresco Labs. “This is also a big step forward for Cresco along our path of unparalleled speed to market, powerful influence in industry development, and proven execution in consumer markets.”
The CY+ dispensary will offer a full selection of premium-quality medical marijuana for patients who have been physician-certified to have any one of 21 approved medical conditions. In addition to the dispensary in Wintersville, Cresco Labs has built an environmentally-advanced 50,000 square foot growing and cultivation facility in Yellow Springs, Ohio which will supply statewide dispensaries with Cresco’s full suite of branded products.
“At Cresco, we pride ourselves on understanding the individual needs of each and every one of our patients. Our Wintersville staff is trained by leading cannabis doctors and researchers across the country to ensure that our patients’ specific needs are consistently met. In Wintersville we will continue to advance our mission of normalizing and professionalizing the cannabis industry for consumers,” Bachtell added.
The Wintersville dispensary features private, one-on-one consultation areas where patients can feel comfortable discussing their conditions or symptoms and exploring the appropriate medical marijuana products. Products offered will range from edibles, vape pens and cartridges to oral sprays, pills, and transdermal patches. Video footage of the new dispensary can be downloaded and viewed here.
About Cresco Labs:
Cresco Labs, based in Chicago, is a leading U.S. cannabis company with experienced management, access to capital and a demonstrated growth strategy. As a differentiated grower, processor and retailer of premium cannabis operating in seven states, the company focuses on entering highly regulated markets with outsized demand potential and high barriers to entry. Its impressive speed-to-market gives Cresco a distinct competitive advantage as it replicates its model to expand its national footprint. Cresco’s proven ability to execute is complemented by a cutting-edge brand strategy spearheaded by several of the brightest minds in consumer marketing in the nation. Cresco’s products are tailored to all major consumer segments: everyday cannabis, medicinally focused, connoisseur grade, and chef inspired edibles by James Beard Award-winning pastry chef Mindy Segal. Learn more about Cresco Labs
Forward Looking Statements
This press release contains “forward-looking information” within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company’s control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as, ‘may,’ ‘will,’ ‘should,’ ‘could,’ ‘would,’ ‘expects,’ ‘plans,’ ‘anticipates,’ ‘believes,’ ‘estimates,’ ‘projects,’ ‘predicts,’ ‘potential’ or ‘continue’ or the negative of those forms or other comparable terms. The Company’s forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the Company’s actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward- looking statements, including but not limited to those risks discussed under “Risk Factors” in the company’s CSE Listing Statement filed with SEDAR; and other factors, many of which are beyond the control of the Company. Readers are cautioned that the foregoing list of factors is not exhaustive. Because of these uncertainties, you should not place undue reliance on the Company’s forward-looking statements. No assurances are given as to the future trading price or trading volumes of Cresco’s shares, nor as to the Company’s financial performance in future financial periods. The Company does not intend to update any of these factors or to publicly announce the result of any revisions to any of the Company’s forward-looking statements contained herein, whether as a result of new information, any future event or otherwise. Except as otherwise indicated, this press release speaks as of the date hereof. The distribution of this press release does not imply that there has been no change in the affairs of the Company after the date hereof or create any duty or commitment to update or supplement any information provided in this press release or otherwise.
Chief Communications Officer 312.953.2767 firstname.lastname@example.org
- Posted In:
- Company News